She’s a huge step in the right direction

Last week, Dr. Heidi Overton sat before the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) as President Donald Trump’s nominee to become the next commissioner of the Food and Drug Administration. She is a strong advocate for pro-life policies, medical freedom, biological gender reality, and Make America Healthy Again (MAHA).

The stakes could hardly be higher because the FDA controls the regulatory framework surrounding the abortion pill. Overton has spent years publicly questioning whether the agency stripped away too many restrictions surrounding mifepristone for chemical abortions and voicing concerns about vaccines and controversial medical procedures.

Now her nomination is facing resistance — even from inside the Republican-led committee. HELP Committee Chairman Sen. Bill Cassidy fiercely questioned Overton’s nomination and you deserve to know the details.

Campaign-finance data from Cassidy’s federal career shows more than 6.1 million dollars in public political support associated with the two main health-sector categories of health professionals and pharmaceuticals and health products.

Cassidy is listed among Congress’s largest recipients. And nearly every other senator has received some level of donations from these same companies too. The only thing more powerful than money on Capitol Hill are voters, and we need your voice to be heard now.

Flood the Senate with your faxes urging support for Dr. Overton.

Last week, Sen. Cassidy started his time questioning Dr. Overton about his “concerns” regarding pharmaceutical drugs and vaccine schedules ... exactly what his biggest donors are concerned about.

The other contentious topic is Dr. Overton's views on chemical abortion. Three years ago, she put her concerns in writing, under the title: “Risking Two Lives—The Dangerous Rise of Chemical Abortion.”

At the time, the Biden administration’s FDA was dismantling safeguards surrounding mifepristone — the first drug typically used in the two-drug chemical-abortion regimen.

First, the FDA eliminated the requirement that women obtain the drug in person. Then came telehealth. Mail-order abortion pills. Pharmacies dispensing mifepristone.

The doctor's office was completely disappearing from this process.

Overton objected.

Her report warned about the rise of tele-abortion and argued that women should receive an in-person medical evaluation before receiving chemical-abortion drugs.

And she did not mince words about why this mattered. Overton and her co-author wrote: “Abortion is corrosive to children, women, and society broadly because it devalues and extinguishes innocent human life.”

Now, President Trump has nominated the very doctor who criticized pushing these abortion pills to become commissioner of the Food and Drug Administration — to be in charge of the FDA itself.

We’ll share below why the timing couldn’t be any better.

Urge the Senate to confirm her now. Send as many faxes as possible today.

The FDA just confirmed that it is running a new safety study of mifepristone. The agency said it was still collecting and evaluating data. After that is complete, the FDA will determine whether “substantive changes" to the drug's special safety rules are needed.

This is exactly what Liberty Counsel Action has been working toward for months. We are excited to see this progress on the abortion pill and even more excited at the possibility that Dr. Overton will, if confirmed, sit in a position of authority over something that she has cared about for years.

Three years ago, Heidi Overton was outside the FDA warning that the federal government had gone too far in loosening abortion-pill safeguards.

Today, she is one step closer to sitting in the chair that oversees that very agency.

And while Washington debates who should lead the FDA, Liberty Counsel Action will continue closely examining the federal policies surrounding chemical abortion and their consequences for women and unborn children.

Please help us continue that work with a monthly gift or the most generous single gift you can provide today.

With your help, we will continue researching these policies, holding federal officials accountable and providing Americans with the information they need about the rapidly changing abortion-pill landscape.

Mat Staver, Chairman
John Stemberger, President
Liberty Counsel Action